Posts tagged IPCI


Analyst Sees Over 160% Upside for IntelliPharmaCeutics Intl Inc (USA) Stock

It can be tricky putting a price tag on a biotech company, especially one that …

A Glimpse Into the Biotech Sector: Intercept Pharmaceuticals Inc (ICPT), IntelliPharmaCeutics Intl Inc (USA) (IPCI)

Intercept Pharmaceuticals Inc (NASDAQ:ICPT) management hosted a conference call this morning to address Ocaliva safety …

Maxim Slashes Price Target For IntelliPharmaCeutics Intl Inc (USA) (IPCI); Here’s Why

In a research report issued Thursday, Maxim analyst Jason Kolbert reiterated a Buy rating on …

IntelliPharmaCeutics Intl Inc (USA) (IPCI) Sinks on Negative FDA Ad Com Vote

IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI) shares are sinking nearly 40% pre-market on robust volume in …

Aegis Drops Coverage of IntelliPharmaCeutics Intl Inc (USA) (IPCI)

In a note issued short while ago, Aegis analyst Difei Yang dropped coverage of IntelliPharmaCeutics Intl …

IntelliPharmaCeutics Intl Inc (USA) Rockets on Generic Glucophage XR Approval From FDA

IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI) received final approval from the FDA for the Company’s abbreviated …

IntelliPharmaCeutics Intl Inc (USA) (IPCI): NDA Acceptance For Rexista May Not Be A Stock-Moving Event, Says Aegis

In a research note released Friday, Aegis analyst Difei Yang reiterated coverage on shares of IntelliPharmaCeutics Intl …

Company Update (NASDAQ:IPCI): IntelliPharmaCeutics Intl Inc (USA) Announces Par Pharmaceutical’s Launch of Additional Strengths of Generic Focalin XR Capsules

IntelliPharmaCeutics Intl Inc (USA) (NASDAQ: IPCI) announced that its United States (“U.S.”) marketing partner, Par Pharmaceutical …